60723-43-5Relevant academic research and scientific papers
A Tricyclic Dehydrorubanone and New Isomers of the Major Quinidine Metabolite
Reisen, Cornelius von,Hoffmann, H. M. R.
, p. 680 - 684 (2007/10/03)
Spiroepoxide 1 was prepared from quinidine and converted into β-amino alcohol 3 (86percent over two steps).Dihydroxylation of enantiopure oxazatricylic olefin (E)-4 provided diastereomeric diols 5a and 5b.Stereospecific conversion of 1,2-secondary, tertiary diol 5b into tetracyclic spiroepoxide 6 was accomplished in high yield by a one-pot tosylation-cyclization procedure. 1,2-Diol cleavage with NaIO4 in 80percent acetic acid afforded the new tricyclic dehydrorubanone 7, containing the 4-oxa-7-azatricyclo3,7>decan-2-one core structure.Similarly, acetylated rubanone 9 was prepared on a 20 g scale.Reduction with NaBH4 in the presence of CeCl3 provided rubanols 10a and 10b (1:1.1).Horner-Wittig reaction of 9 with diethyl cyanomethylphosphonate was (Z)-selective, furnishing unsaturated nitrile (Z)-13.Conversion into the α,β-unsaturated aldehyde (Z)-14 and reduction afforded enantiopure allylic alcohol (Z)-12, which is a new isomer of the key quinidine metabolite 15. - Keywords: amino alcohols; asymmetric ayntheses; dihydroxylations; diol cleavage Horner-Wittig reaction
(3S)-3-Hydroxyquinidine, the Major Biotransformation Product of Quinidine. Synthesis and Conformational Studies. X-Ray Molecular Structure of (3S)-3-Hydroxyquinidine Methanesulphonate
Carroll, F. Ivy,Abraham, Philip,Gaetano, Kevan,Mascarella, S. Wayne,Wohl, Ronald A.,et al.
, p. 3017 - 3026 (2007/10/02)
(3S)-3-Hydroxyquinidine, the major metabolite of the Cinchona alkaloid quinidine, was prepared by synthetic chemical modification or microbial oxidation of quinidine.The structure of this metabolite has been demonstrated to be (3S)-3-hydroxyquinidine by 1H and 13C NMR, IR, UV and mass spectral analysis.Previously published comparisons of the 13C NMR spectra of 3-hydroxyquinidine and model compounds were used to establish the absolute stereochemistry of the metabolite (see ref. 8).This assignment has been verified by single-crystal X-ray analysis of (3S)-3-hydroxyquinidine methanesulphonate.The gas- and solution-phase conformational preference of the metabolite derived from molecular modelling and NOE studies are compared with the conformation observed by X-ray crystallography.
